News | January 03, 2011

FDA Gives 510(k) Clearance for Spot Scanning Software

January 3, 2011 – The U.S. Food and Drug Administration (FDA) has given 510(k) clearance for software used for planning spot scanning. The XiO treatment planning software, from Elekta, is used with proton therapy, which helps clinicians deliver a highly targeted dose to a tumor.

Spot scanning is a proton therapy delivery method that involves constructing a highly conformal dose to the tumor by using thousands of small individual beamlets instead of a single large beam. This approach enables intensity modulated proton therapy (IMPT).

The software provides tools to facilitate rapid positioning of spots to construct the dose to the tumor, in addition to a proven dose calculation algorithm to optimize each beam.

"The completely automated optimization of the spot deliveries allows clinicians to produce treatment plans with a high degree of conformality around the target, therefore, minimizing the dose to adjacent healthy tissue," said Virgil Willcut, vice president of product management, physics and research for Elekta treatment planning. "Spot scanning especially is important for pediatric patients since it provides better normal tissue sparing and lower neutron doses than conventional proton planning, both of which reduce the chance of radiation induced side effects for a cohort of patients that are still developing and have long life expectancies."

The software has been in clinical use for nearly a decade.

For more information: www.elekta.com.

Related Content

RaySearch Releases New Version of RayCare OIS
Technology | Oncology Information Management Systems (OIMS) | July 13, 2018
RaySearch has released RayCare 2A, the latest version of its flagship oncology information system (OIS). RayCare is...
Lack of Insurance Coverage Delaying Proton Therapy Clinical Trials
News | Proton Therapy | July 12, 2018
Randomized clinical trials are the gold standard of cancer research and can shed light on whether innovative, new...
Bruce Power Joins Forces With ITM to Supply Lutetium-177 for Cancer Therapy
News | Radiation Therapy | July 11, 2018
Canadian nuclear power company Bruce Power and German-based Isotope Technologies Garching (ITG) signed an agreement to...
Guerbet, IBM Watson Health Partner on Artificial Intelligence for Liver Imaging
News | Clinical Decision Support | July 10, 2018
Guerbet announced it has signed an exclusive joint development agreement with IBM Watson Health to develop an...
MedStar Georgetown University Hospital Now Clinical With RayStation and Hyperscan
News | Treatment Planning | July 05, 2018
MedStar Georgetown University Hospital in Washington D.C., has begun patient treatments using the RayStation treatment...
Northern Centre for Cancer Care (NCCC)

Northern Centre for Cancer Care (NCCC).

Sponsored Content | Case Study | Radiation Therapy | July 05, 2018
Established in 2009, Northern Centre for Cancer Care (NCCC) is the largest center of its kind in the north of England....
Feature | Proton Therapy | July 03, 2018 | By Jeff Zagoudis
The Alliance for Proton Therapy Access (APTA) released a national report in late May revealing the heavy emotional and...
Feature | Treatment Planning | July 03, 2018 | By Jeff Zagoudis
A new software developed and recently tested at the MD Anderson Cancer Center demonstrated the ability to largely aut
Researcher Investigates Eliminating Radiation for HER2-Positive Breast Cancer
News | Radiation Therapy | July 02, 2018
Researchers at The University of Kansas Cancer Center have launched a clinical trial that eliminates radiation from the...
FDA Clears Bay Labs' EchoMD AutoEF Software for AI Echo Analysis
Technology | Cardiovascular Ultrasound | June 19, 2018
Cardiovascular imaging artificial intelligence (AI) company Bay Labs announced its EchoMD AutoEF software received 510(...
Overlay Init